Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.2 BRL | +1.46% | +2.03% | +10.15% |
06-08 | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
06-07 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
Filters
- Stock Market
- Equities
- PFE Stock
- PFIZ34 Stock
- News Pfizer Inc.